Literature DB >> 7925097

Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation.

T Ikonen1, J J Palvimo, P J Kallio, P Reinikainen, O A Jänne.   

Abstract

The effect of modulators of protein phosphorylation on the transcriptional activity of the androgen receptor (AR) was studied under transient expression conditions. Activators of protein kinase-A [8-bromo-cAMP (8-Br-cAMP)] and protein kinase-C (phorbol 12-myristate 13-acetate) or an inhibitor of protein phosphatase-1 and -2A (okadaic acid) influenced minimally pMMTV-chloramphenicol acetyl-transferase (CAT) activity in CV-1 cells cotransfected with an AR expression plasmid in the absence of androgen. In the presence of testosterone, however, all compounds enhanced AR-mediated transactivation by 2- to 4-fold. A nonsteroidal antiandrogen, Casodex, behaved as a pure antagonist; it blunted the action of testosterone and was not rendered agonistic by activators of protein kinase-A. A reporter plasmid containing two androgen response elements (AREs) in front of the thymidine kinase promoter (pARE2tk-CAT) was also used to examine promoter specificity. It was activated by 8-Br-cAMP, forskolin, or okadaic acid even without AR or androgen. However, when forskolin or okadaic acid was used together with androgen and AR, the resulting AR-dependent transactivation of pARE2tk-CAT was more than additive. Intact DNA- and ligand-binding domains, but not the N-terminal amino acid residues 40-147, of the receptor were mandatory for the synergism between protein kinase-A activators and androgen. Immunoreactive AR content in transfected COS-1 cells was not influenced by exposure to 8-Br-cAMP. Similar results were obtained by ligand binding assays. Quantitative or qualitative differences were not observed in DNA-binding characteristics between receptors extracted from cells treated with testosterone with or without protein kinase-A activator. Collectively, the synergistic stimulation of AR-dependent transactivation by androgen and protein kinase activators is not due to changes in cellular AR content or affinity of the receptor for the cognate DNA element; rather, this phenomenon seems to result from altered interaction of ligand-activated AR with other proteins in the transcription machinery.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925097     DOI: 10.1210/endo.135.4.7925097

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  35 in total

1.  Androgen receptor repression of GnRH gene transcription.

Authors:  Melissa J Brayman; Patricia A Pepa; Sara E Berdy; Pamela L Mellon
Journal:  Mol Endocrinol       Date:  2011-11-10

Review 2.  Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisense oligonucleotides to enhance androgen- and chemo-sensitivity in prostate cancer.

Authors:  Martin E Gleave; Toby Zellweger; Kim Chi; Hideaki Miyake; Satoshi Kiyama; Laura July; Simon Leung
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850

3.  CREB-binding protein in androgen receptor-mediated signaling.

Authors:  P Aarnisalo; J J Palvimo; O A Jänne
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

Review 4.  The convergence of hormone regulation and cell cycle in prostate physiology and prostate tumorigenesis.

Authors:  Joanne N Davis; Mark L Day
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

5.  Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription.

Authors:  A M Moilanen; H Poukka; U Karvonen; M Häkli; O A Jänne; J J Palvimo
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

6.  Activation of androgen receptor function by a novel nuclear protein kinase.

Authors:  A M Moilanen; U Karvonen; H Poukka; O A Jänne; J J Palvimo
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

7.  Checkpoint Kinase 2 Negatively Regulates Androgen Sensitivity and Prostate Cancer Cell Growth.

Authors:  Huy Q Ta; Melissa L Ivey; Henry F Frierson; Mark R Conaway; Jaroslaw Dziegielewski; James M Larner; Daniel Gioeli
Journal:  Cancer Res       Date:  2015-11-16       Impact factor: 12.701

8.  Steroid-regulated growth of DDT1MF-2 cells is profoundly influenced by culture conditions.

Authors:  D J Lamb; M Ray
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-12       Impact factor: 2.416

9.  Androgen receptor phosphorylation and activity are regulated by an association with protein phosphatase 1.

Authors:  Shaoyong Chen; Cristina T Kesler; Bryce M Paschal; Steven P Balk
Journal:  J Biol Chem       Date:  2009-07-21       Impact factor: 5.157

10.  A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression.

Authors:  Feng Jin; Joseph D Fondell
Journal:  Nucleic Acids Res       Date:  2009-06-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.